Moneycontrol
HomeNewsBusinessStocksStrides Arcolab gains 3.7% on US FDA approval
Trending Topics

Strides Arcolab gains 3.7% on US FDA approval

Stride Arcolab oral dosage facility continues to receive approval from US FDA, reports CNBC-TV18. It touched an intraday high of Rs 299.70 and an intraday low of Rs 282.50. At 13:59 hrs the share was quoting at Rs 295, up Rs 10.75, or 3.78%.

September 14, 2011 / 14:09 IST
Story continues below Advertisement

Stride Arcolab touched an intraday high of Rs 299.70 and an intraday low of Rs 282.50. At 13:59 hrs the share was quoting at Rs 295, up Rs 10.75, or 3.78%.


The company's oral dosage facility continues to receive approval from US FDA, reports CNBC-TV18.
 
It was trading with volumes of 42,322 shares. In the previous trading session, the share closed down 0.94% or Rs 2.70 at Rs 284.25.

Share Price Movement During The Last 12 Months
PeriodPriceLatest PriceGain/Loss (Rs.)% Gain/Loss
3-Days288.50295.006.502.25
5-Days292.05295.002.951.01
7-Days288.45295.006.552.27
15-Days290.40295.004.601.58
1-Month302.55295.00-7.55-2.50
3-Month361.80295.00-66.80-18.46
6-Month362.75295.00-67.75-18.68
9-Month423.00295.00-128.00-30.26
1-Year428.85295.00-133.85-31.21

Story continues below Advertisement
first published: Sep 14, 2011 02:01 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!